Genmab A/S - American Depositary Shares — Rendiconto Finanziario (NASDAQ:GMAB)

Genmab A/S - American Depositary Shares

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

GMAB

Financials

Genmab A/S - American Depositary Shares

Notizie

Genmab: Multiple Binaries Could Alter The Thesis (NASDAQ:GMAB)

JNJ: Success In Multiple Myeloma Underpins $25B In Growth By 2030 (NYSE:JNJ)

Wolfe Research avvia la copertura del titolo Genmab con rating outperform

Il consiglio di Genmab nomina la leadership e assegna premi azionari

Biopharma europea resta scommessa difensiva su crescita stabile e liquidità: Bernstein

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.00%

Harbor Health Care ETF Q4 2025 Portfolio Review

Denmark stocks higher at close of trade; OMX Copenhagen 20 up 0.20%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.23%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 2.42%

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.18%

Wells Fargo avvia la copertura su Genmab con rating overweight